Nasdaq-listed Windtree Therapeutics will raise $520 million through an equity line of credit and a stock purchase agreement, ...

Biotech firm Windtree plans $520M Binance Coin bet via stock deals and credit line, pending shareholder approval amid mixed ...

Nasdaq-listed biotech company Windtree Therapeutics (WINT) announced it has signed a $500 million equity line of credit (ELOC ...

Windtree Therapeutics, recently made waves by announcing plans to allocate up to $700 million toward acquiring BNB.

BNB (BNB), formerly known as Binance Coin, edges lower after hitting a new all-time high of $855 at press time on Monday. The ...

Windtree Therapeutics secures $520M to pivot into a BNB-focused crypto treasury strategy, marking a bold move for corporate ...

Windtree Therapeutics has said it is raising another $520 million to buy up BNB, the fifth-largest digital coin, to put on ...

BNB (BNB) price is down slightly to trade at $771 on Friday, after correcting from its new record high of $809, reached on ...

Windtree Therapeutics has entered agreements to raise up to $520 million for BNB cryptocurrency acquisition, with a total commitment nearing $700 million. The company plans to direct 99% of funds ...

The rebound was fueled by Windtree Therapeutics' commitment to invest $520 million in BNB for its corporate treasury.

Crypto exchange Kraken will custody and manage BNB assets for Windtree Therapeutics' crypto treasury plan tied to Binance ...

"We are excited to incorporate these new facilities to enable our future BNB acquisitions as part of our BNB treasury strategy," stated Jed Latkin, CEO of Windtree. "Pending stockholder approval, the ...